BJP RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Otani, K.
Right arrow Articles by Fukushima, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Otani, K.
Right arrow Articles by Fukushima, Y.

The British Journal of Psychiatry 158: 850-853 (1991)
© 1991 The Royal College of Psychiatrists

Is the predisposition to neuroleptic malignant syndrome genetically transmitted?

K Otani, M Horiuchi, T Kondo, S Kaneko and Y Fukushima
Department of Neuropsychiatry, Hirosaki University Hospital, Japan.

A Japanese family consisting of a mother and her two daughters, all experienced NMS on therapeutic or subtherapeutic doses of neuroleptics. The mother and the elder daughter had past histories of severe neuroleptic-induced extrapyramidal symptoms. The predisposition to this syndrome may be genetically transmitted. We suggest that neuroleptic treatment should be introduced with extreme caution to a patient with a family history of NMS.


This article has been cited by other articles:


Home page
 Am. J. PsychiatryHome page
A. Suzuki, T. Kondo, K. Otani, K. Mihara, N. Yasui-Furukori, A. Sano, K. Koshiro, and S. Kaneko
Association of the TaqI A Polymorphism of the Dopamine D2 Receptor Gene With Predisposition to Neuroleptic Malignant Syndrome
Am J Psychiatry, October 1, 2001; 158(10): 1714 - 1716.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. J. Gurrera
Sympathoadrenal Hyperactivity and the Etiology of Neuroleptic Malignant Syndrome
Am J Psychiatry, February 1, 1999; 156(2): 169 - 180.
[Abstract] [Full Text]

Home page
 Psychiatr. Serv.Home page
A. L. Pelonero, J. L. Levenson, and A. K. Pandurangi
Neuroleptic Malignant Syndrome: A Review
Psychiatr Serv, September 1, 1998; 49(9): 1163 - 1172.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
C. Kawanishi, T. Hanihara, Y. Shimoda, K. Suzuki, N. Sugiyama, H. Onishi, T. Miyakawa, Y. Yamada, and K. Kosaka
Lack of Association Between Neuroleptic Malignant Syndrome and Polymorphisms in the 5-HT1A and 5-HT2A Receptor Genes
Am J Psychiatry, September 1, 1998; 155(9): 1275 - 1277.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1991 The Royal College of Psychiatrists.